Risk of venous thromboembolism in patients receiving adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide for early breast cancer

Citation

Hoy, J, Neeman, T, Stuart-Harris, R et al 2009, 'Risk of venous thromboembolism in patients receiving adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide for early breast cancer', Asia-Pacific Journal of Clinical Oncology, vol. 5, pp. 129-136.

Year

2009

ANU Authors

Field of Research

  • Chemotherapy

Updated:  04 August 2020 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers